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Objectives The aim of the study was to analyze the molecular mechanisms activated during postinfarction remodeling in
human hearts.
Background The molecular mechanisms of initial response to ischemic insult in the heart and the pathways involved in com-
pensation and remodeling are still largely unknown.
Methods Up-regulation or down-regulation of gene expression in the human viable peri-infarct (vs. remote) myocardial re-
gion was investigated by complementary deoxyribonucleic acid array technology and confirmed at a single-gene/
protein level with reverse transcriptase polymerase chain reaction and immunohistochemistry. An in vitro model
of cardiomyocyte hypoxia in HL1 cells was used to validate anti-apoptotic effects of the candidate gene/protein
and to assess the associated downstream cascade. Finally, a mouse model of myocardial infarction was used to
test the in vivo effects of exogenous transfection with the candidate gene/protein.
Results Protein disulfide isomerase (PDI), a member of the unfolded protein response, is 3-fold up-regulated in the via-
ble peri-infarct myocardial region, and in a postmortem model, its expression is significantly inversely correlated
with apoptotic rate and with presence of heart failure (HF) and biventricular dilatation. Induced PDI expression in
HL1 cells conferred protection from hypoxia-induced apoptosis. Adenoviral-mediated PDI gene transfer to the
mouse heart resulted in 2.5-fold smaller infarct size, significantly reduced cardiomyocyte apoptosis in the peri-
infarct region, and smaller left ventricular end-diastolic diameter versus mice treated with a transgene-null ad-
enoviral vector.
Conclusions These results suggest that PDI promotes survival after ischemic damage and that zinc-superoxide dismutase is
one of the PDI molecular targets. Pharmacological modulation of this pathway might prove useful for future
prevention and treatment of HF. (J Am Coll Cardiol 2007;50:1029–37) © 2007 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.06.006S
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mrogressive remodeling in ventricular architecture occurs in
nfarcted and noninfarcted regions, after transmural myo-
ardial infarction (MI). Initially, remodeling is required for
aintenance of cardiac output but ultimately leads to left
entricular dysfunction (LVD) and heart failure (HF) (1).
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bout the profound changes within the ischemic and non-
schemic myocardium (2). Experimental studies in animal
odels of MI have identified several candidate genes whose
xpression is altered after MI. These include genes involved
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tile apparatus, connective tissue,
and in the compensatory re-
sponse to improve hemodynam-
ics (3). However, owing to the
difficulties in obtaining ribonu-
cleic acid (RNA) from infarcted
hearts, our knowledge of these
events in humans is still limited.
Different phenomena occur in
MI and are important determi-
nants of HF development: cardi-
omyocyte loss due to necrosis
occurring early during acute MI,
apoptosis that might occur in the
subsequent days or weeks in the
peri-infarcted region and that
ight play a significant role in expansion of dysfunctional
rea and therefore in HF development, and fibrosis occur-
ing as replacement of lost myocardium and contributing to
yocardial stiffness (4). Experimental animal studies reveal-
ng beneficial effects of inhibiting apoptosis support a key
ole of apoptosis in postinfarction remodeling (5). There-
ore, understanding these apoptotic events might provide
ovel insights into HF and its management. We report that
he protein disulfide isomerase (PDI) gene, a member of the
nfolded protein response (UPR) regulon, is up-regulated
n the viable peri-infarct myocardial region of human hearts
ithin the first days after infarction. The functional conse-
uences of this up-regulation, as demonstrated by in vitro
nd in vivo models of cardiac hypoxia-ischemia, are a
ignificant decrease in the rate of cardiomyocyte apoptosis
nd, consequently, in a more favorable ventricular remod-
ling. These results, for the first time, strongly suggest that
DI plays a key protective role in the myocardium after an
nfarct and identify PDI as a potential target for future
harmacological treatments.
ethods
ostmortem analysis: characteristics of selected cases.
ighteen independent cases were selected at time of autopsy
Department of Pathology, University of Trieste, Italy)
ccording to the following inclusion and exclusion criteria:
) death occurring 10 to 60 days after acute MI; 2) no
vidence of re-infarction at clinical and pathologic assess-
ent; and 3) total occlusion of the infarct-related artery as
efined by absence of residual lumen at pathologic exami-
ation. All subjects were hospitalized before death. Clinical
nd pathological characteristics of the subjects are shown
able 1.
athological examination and determination of apoptotic
ardiomyocytes. Autopsy was performed within 24 h after
eath in all cases (median 16 h). Gross examination of the
earts and determination of apoptotic cardiomyocytes by
Abbreviations
and Acronyms
HF  heart failure
LVD  left ventricular
dysfunction
LVEDD  left ventricular
end-diastolic diameter
LVESD  left ventricular
end-systolic diameter
MI  myocardial infarction
PDI  protein disulfide
isomerase
qPCR  quantitative
reverse transcriptase
polymerase chain reactiono-staining for terminal deoxynucleotidyltransferase- eediated dUTP nick end labeling (TUNEL), caspase-3, or
uscle-actin were performed as described (6). Tissue spec-
mens (125 to 1,000 mm3) were obtained at sites of MI and
n regions of the right ventricle remote from the infarcted
rea supplied by a patent coronary artery. Specimens were
ither snap-frozen for RNA extraction or fixed in 10%
araformaldehyde in 0.1 mol/l phosphate-buffered saline.
he PDI expression was detected with a rabbit polyclonal
ntibody anti-PDI H-160 (Santa Cruz Biotechnology,
anta Cruz, California) at 1:200 dilution. Immunohisto-
hemistry and TUNEL scores were performed by 2 pathol-
gists (F.F. and A.B.) unaware of clinical and PDI data.
NA extraction, complementary deoxyribonucleic acid
rray analysis and reverse transcriptase polymerase chain
eaction (RT-PCR). Total RNA was extracted from myo-
ardial autoptic samples by using RNeasy Fibrous-Tissue-
xtraction-kit (Qiagen, Hilden, Germany). Total RNA was
urified with RNeasy mini-columns (Qiagen). Five micro-
rams of pooled RNAs (from border and remote zones)
ere used to perform an Atlas Human Cardiovascular array
Clontech, Mountain View, California) analysis. The choice
f pooled remote myocardium as comparison was consid-
red essential in order to have an internal (rather than
linico-Pathological Characteristics of the Patients
Table 1 Clinico-Pathological Characteristics of the Patients
Age (yrs) 72 (63–78)
Male gender 13 (72%)
Time to death after MI (days) 14 (10–50)
Fibrinolysis 6 (33%)
Transmural infarction 15 (83%)
Infarct extent
Small (10%) 2
Moderate (10%–20%) 8
Extensive (30%) 8
Anterior AMI 7 (38%)
Previous additional AMI 9 (50%)
Pathological characteristics
Heart weight (g) 510 (470–578)
Transverse diameter (mm) 125 (121–136)
Longitudinal diameter (mm) 104 (100–115)
LV free wall thickness (mm) 13 (11–16)
Diameter-to-wall thickness ratio 9.8 (7.9–11.6)
Right ventricular enlargement 8 (47%)
Multivessel CAD 8 (47%)
Associated conditions
Diabetes 5 (28%)
Heart failure 11 (61%)
Trauma 1 (6%)
Respiratory failure (including sepsis) 12 (67%)
Gastrointestinal bleed 3 (17%)
Renal failure 5 (28%)
Stroke 2 (11%)
Pulmonary embolism 1 (6%)
 18. Quantitative results are expressed as median and interquartile range.
AMI  acute myocardial infarction; CAD  coronary artery disease; LV  left ventricular; MI 
yocardial infarction.xternal) control and reduce to the minimum the possibility
o
s
Q
i
i
t
t
s
t
b
(
t
T
G
5
r
C
p
A
C
K
T
t
(
c
a
W
f
(
a
d
I
w
T
3
P
G
E
T
S
4
C
f
(
n
G
5
G
G
P
A
S
T
c
P
i
m
i
t
C
v
(
t
p
a
t
S
r
m
G
s
H
p
F
i
b
(
s
u
q
S
R
T
C
r
m
T
G
C
G
m
C
C
G
G
f
r
m
m
T
G
C
t
a
S
t
N
a
A
w
1031JACC Vol. 50, No. 11, 2007 Severino et al.
September 11, 2007:1029–37 PDI Over-Expression in Human Infarcted Heartsf postmortem autolysis-related changes. Arrays were
canned with a PhosphorImager and analyzed by Image-
uant 5.0 software (Molecular Dynamics, Sunnyvale, Cal-
fornia). The experiment was performed in duplicate, with 2
ndependent RNA preparations. The PDI up-regulation in
he border zone was confirmed by semi-quantitative reverse
ranscriptase polymerase chain reaction (qPCR) assay on the
ame pooled RNAs. Two micrograms of total RNA were
reated with M-MLV reverse transcriptase (Invitrogen, Carls-
ad, California) and amplified with Taq DNA Polymerase
Promega, Madison, Wisconsin). The following oligonucleo-
ides were used: PDI-forward:5=-GGACCACGTCT-
GGTGCTGCG-3= , PDI-reverse:5=-GATGAC-
GCCACCTCGCTGCTGGA-3=, -actin-forward:
=-AAGAGAGGCATCCTCACCCT-3=, -actin-
everse:5=-ATCTCCTGCTCGAACTCCAG-3=.
ulture of HL1 cells. HL1 cells are differentiated and
roliferating atrial cardiomyocytes derived from mouse
T-1 cells (7). Cells were cultured as described in
laycomb-Medium (JRH Biosciences, Andover, United
ingdom).
reatment with hypoxic stress. Subconfluent HL1 cul-
ures were kept at 37°C in a humidified sealed chamber
Billups-Rothenburg, Del Mar, California) gassed with 5%
arbon dioxide- 95% gaseous nitrogen (5% oxygen) for 24
nd 48 h.
estern blot analysis. Immunoblot analysis was per-
ormed with rabbit polyclonal antibody anti-PDI H-160
Santa Cruz Biotechnology) or mouse monoclonal antibody
nti–-actin C-2 (Santa Cruz Biotechnology) at 1:200
ilution.
solation of PDI cDNA. Full-length human PDI cDNA
as isolated from Phoenix cell line total RNA by RT-PCR.
he cDNA was subcloned in P-dominant cDNA (pcDNA)
.1() expression vector with the following oligonucleotides:
D I - f o r w a r d - B a m H I : 5 = - G A T C G G A T C C A T -
CTGCGCCGCGCTCTGCTGT-3=, PDI-reverse-
c o R I : 5 = - G A T C G A A T T C T T A C A G T T C A -
CTTTCACAGCTTTCTG-3=.
ite-directed mutagenesis. The point mutants PDI-N (C36/
0S) and PDI-C (C383/S387) were generated with a Quick-
hange site-directed mutagenesis kit (Stratagene, La Jolla, Cali-
ornia) on the basis of the long-PCR method. The wild-type PDI
PDI-wt) pcDNA3 was used as a template. The following oligo-
ucleotides were used: PDI-N(1):5=-GGCCAGAGCCTT-
GAGTGGCCAGACCAGGGGGCATG-3=, PDI-N(2):
=-CATGCCCCCTGGTCTGGCCACTCTAAG-
CTCTGGCC-3=; PDI-C(1):5=-GAGCCAACT-
TTTGGAGTGACCAGACCATGGGGCATAG-3=,
DI-C(2):5=-CTATGCCCCATGGTCTGGTCACTCC-
AACAGTTGGCTC-3=.
table overexpression of PDI-wt and PDI mutants.
ransfection of PDI-wt, PDI-N, and PDI-C into HL1
ells was carried out by Lipofectamine (Invitrogen). The
DI-transfected or pcDNA3-transfected cells were selectedn the presence of 700 g/ml G418 for 2 weeks and then Caintained in the presence of 300 g/ml G418. Finally,
ndividual colonies were isolated, expanded, and assayed for
he expression of the transfected gene by Western blotting.
onstruction of adenoviral vectors. Recombinant adeno-
iral vectors were constructed with the Ad-Easy system
Stratagene). Viral titers were estimated by serial dilution of
he viral stocks in transduced 293 cells and expressed as
laque-forming units/ml (PFU/ml). Viral stocks were neg-
tive for presence of replication-competent adenovirus as
ested on A549 cells.
uperoxide dismutase activity measurements. Cells were
esuspended in TSS (145 mmol/l sodium chloride; 2.5
mol/l potassium chloride; 10 mmol/l Hepes; 10 mmol/l
lucose; 1.5 mmol/l calcium chloride; 1.2 mmol/l magne-
ium chloride; pH 7.4) and incubated for 1 min at 37°C.
ydrogen peroxide contents were measured by horseradish
eroxidase-enhanced chemiluminescence as described (8).
low cytometric analysis. The HL1 cells were fixed in
ce-cold 70% ethanol. After resuspension, cells were incu-
ated with propidium iodide (50 g/ml) and RNaseI
1 mg/ml) for 30 min. Flow cytometry and Expo32 ADC
oftware (Beckman Coulter, Fullerton, California) were
sed for analysis of sub-G1 DNA content.
PCR. Quantitative PCR was done with the Platinum
YBR Green qPCR-superMix-UDG-Kit (Invitrogen) with
otor-Gene RG3000 from Corbett Research as described (9).
he following oligonucleotides were used: mPDI-forward-
AAGTTCTTCAAGAATGGAGACACAGC; mPDI-
everse-TTCTTCAGCCAGTTGACAATGTCATC;
ATF6alpha-forward- CGACGTTGTTTGCTGAACT-
GGCTA; mATF6alpha-reverse-CTGACTCCCAAG-
CATCAAATCC; mBIP-forward-CGATAATCAGC-
AACTGTAACAATCAAGG; mBIP-rever se-
G A A T T C C A G T C A G A T C A A A T G T A C C C ;
GRP94-forward-CACACTAGGTCGTGGAACAA-
AATTAC; mGRP94-reverse-TCTTGCTACTCCA-
ACGTAGATGG; mEro1-forward-GGTGAACTT-
AAGAAGCCTTGTCC; mEro1-reverse-CTT-
TAGCTCGCAGACTTAATTCCATCAGG; mPERK-
orward-GCGACGGAGCCCGATGACG; mPERK-
everse-GCATCCAGTGCAGCGATTCGTCC;
IRE1a-forward-TCACTGCCGGAAGACGACGTGG;
IRE1a-reverse-CCACAGGACATCCCCAGAT-
CACTGTCC; m-actin-forward-GATTACTGCTCT-
GCTCCTAG; m-actin-reverse-ACTCATCGTA-
TCCTGCTTGC.
The housekeeping gene -actin was used to normalize
he results, and cDNA from untreated HL1 cells was used
s a reference.
urgical procedures for in vivo experiments. Experimen-
al procedures complied with the Guidelines of the Italian
ational Institutes of Health, with the Guide for the Care
nd Use of Laboratory Animals (Institute of Laboratory
nimal Resources, National Academy of Sciences), and
ere approved by the Institutional Animal Care and Use
ommittee. Myocardial infarction was induced in 34
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s previously described (10). We set the protocol for in vivo
denoviral-mediated gene transfer as follows: 4 injections, 2
or each side flanking the left coronary artery of adenoviral
ectors, were performed into the ventricular wall. The
olume of each injection was 2.5 l (approximate titer 1 
010 PFU/ml). The size of the heart of animals (8-week-old
56/bl6 mice) hampered both increments in the number of
njections and volume for single administration. The chest
as closed and mice were allowed to recover. After 48 h
nimals were re-operated and the left coronary artery was
igated. Sham-operated mice were treated similarly (without
denovirus injection), except that the ligature around the
oronary artery was not tied. Animals were killed 1 week
fter surgery, after echocardiography.
valuation of myocardial function in vivo. Echocardio-
raphy was performed in 14 conscious mice (7 AdPDI/
reen fluorescent protein [GFP]-injected and 7 Adnull/
FP control subjects) with a Sequoia 256c echocardiogra-
hy device (National Ultrasound, Duluth, Georgia)
quipped with a 13-MHz linear transducer as described
10). Left ventricular end-diastolic diameter (LVEDD) and
eft ventricular end-systolic diameter (LVESD) were
easured.
istological and immunohistochemical analysis. After
chocardiography, hearts were recovered for histology as
escribed (10). Adenoviral-mediated gene transfer was de-
ermined with rabbit polyclonal antibodies for GFP
ABCAM, Cambridge, United Kingdom) and PDI (anti-
DI H-160, Santa Cruz Biotechnology). Apoptosis was
etected with co-staining for TUNEL (Apoptag-Oncor,
aithersburg, Maryland) and muscle actin.
tatistical analysis. Statistical analysis was performed with
PSS 10.1 for Windows (SPSS, Chicago, Illinois). For data
btained from human subjects, quantitative results are
xpressed as median (interquartile range), because of poten-
ial deviations from assumptions of normality. The uncor-
ected chi-square test or the Fisher exact test was used for
ategorical variables, when appropriate. Continuous vari-
bles were analyzed with Mann-Whitney U or Wilcoxon
ank sum tests for unpaired and paired data, respectively.
orrelation between continuous variables was analyzed with
he Spearman test. For animal data, quantitative results are
xpressed as mean  SE. Continuous variables were ana-
yzed with analysis of variance to compare 3 or more groups
nd, when p  0.05, the Student t test for unpaired data
with Bonferroni’s correction) was used to compare 2 of 3
roups at a time. Two-tailed statistical significance was at
he 0.05 level.
esults
poptosis in human postmortem specimens. Apoptotic
ardiomyocytes were detected both in the peri-infarct and
emote areas in 18 infarcted hearts. The apoptotic index was
ignificantly higher in the peri-infarct versus remote areas O8.9% [5.1 to 12.6] vs. 0.7% [0.5 to 0.9], p  0.001). The
poptotic rate both in the peri-infarct and remote areas
ignificantly correlated with increasing cardiac transverse
iameter (r  0.51, p  0.022; r  0.48, p  0.048,
espectively) and cardiac weight (r0.47, p 0.042; r
0.44, p  0.050, respectively).
DI is up-regulated after infarction. A human Cardio-
ascular Array was used to compare the RNA transcripts
rom 2 different pools: 1 from samples obtained in the
eri-infarct region and 1 from a remote area. The PDI gene
as up-regulated 3-fold in the RNA extracted from the
eri-infarct areas. Semiquantitative RT-PCR was per-
ormed on the same pooled RNAs to confirm differential
xpression (Fig. 1A). Immunohistochemical analysis of PDI
xpression on all human samples confirmed the up-
egulation of PDI at the protein level in the peri-infarct
reas (Figs. 1B and 1C). Finally, co-staining for PDI and
UNEL showed that most of the cardiomyocytes over-
xpressing PDI were TUNEL negative (Fig. 1D).
DI expression, cardiomyocyte apoptosis, and cardiac
emodeling. The PDI was expressed in the peri-infarct
reas in all 18 patients investigated but only in 7 in the
emote regions (100% vs. 39% of remote regions, p 
.001). Expression in peri-infarct regions was mild in 3
ases (17%), moderate in 5 (28%), and intense in the
emaining 10 cases (55%). The intensity of PDI expression
as significantly inversely correlated with the apoptotic rate
r  0.55, p  0.021). In the 10 cases with intense PDI
xpression the apoptotic rate was significantly lower (7.1%
1.4 to 9.0] vs. 12.0% [9.1 to 14.1], p  0.012) (Fig. 1E)
han in the 8 cases with mild or moderate expression (Fig.
E) (Table 2). Interestingly, subjects with intense PDI
xpression were less likely to be suffering from stage-C New
ork Heart Association functional class IV congestive HF
30% vs. 88%, p 0.025) (Fig. 1F) and to have biventricular
nlargement at postmortem examination (20% vs. 88%, p
.015) (Fig. 1G).
DI is over-expressed in vitro under hypoxic conditions
nd protects cardiomyocytes from apoptosis. Murine
L1 cells were subjected to hypoxic stress, and proteins
ere extracted at various time points. The PDI protein level
ncrease was detected by Western blot analysis (Fig. 2A).
hese data suggest that the over-expression of PDI is
hysiologically relevant and might be beneficial for cells to
urvive hypoxic conditions. To test this hypothesis, we
nvestigated the functional consequences of PDI over-
xpression after hypoxic stress in cardiomyocytes. Wild-type
DI as well as 2 enzymatically inactive point mutants,
DI-N [C36/40S] and PDI-C [C383/S387], mapped in 2
hioredoxin-like domains located in the N-terminal and
-terminal regions of the protein (Fig. 2B), were over-
xpressed in HL1 cells. Increased levels of PDI in trans-
ected cells were verified by Western blot analysis. Stable
ransfectants were subjected to hypoxic stress, and apoptotic
ates were measured by flow cytometric (FACS) analysis.
ver-expression of PDI was able to significantly decrease
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September 11, 2007:1029–37 PDI Over-Expression in Human Infarcted Heartshe apoptotic rate in normoxic and hypoxic cardiomyocytes
t 24 h and 48 h, respectively (p  0.001). Over-expression
f both enzymatically inactive point mutants rather in-
reased the number of apoptotic cells compared with the
ontrol in normoxic and hypoxic conditions at 24 h and 48
(p  0.001) (Fig. 2C). These data indicate that the
Figure 1 Analysis of PDI Expression on Autoptic Human Infarct
(A) Semiquantitative reverse transcriptase polymerase chain reaction showing hig
(RNA) extracted close to the infarcted area, with respect to the RNA extracted in th
emic heart as well as a reaction made with no RNA were used as controls. (B) Im
tion 40). (C) Immunohistochemical expression of PDI in the area remote from th
deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) in the infarc
as indicated by an asterisk (original magnification 40). (E) Correlation between P
expression and congestive heart failure (CHF) signs. (G) Correlation between PDI e
ifferential Characteristics of the Patients in theGroups (High and Low PDI Expression in theeri-Infarct Regio )
Table 2
Differential Characteristics of the Patients in the
2 Groups (High and Low PDI Expression in the
Peri-Infarct Region)
Intense PDI
Expression
(PDI  3)
n  10
Mild-to-
Moderate
PDI Expression
(PDI <3)
n  8
Age (yrs) 70 (62–72) 77 (72–80)
Male gender 7 (70%) 6 (75%)
Time to death after MI (days) 16 (12–16) 18 (10–52)
Heart failure 3 (30%) 7 (88%)*
Infarct extent
Small (10%) 2 2
Moderate (10%–20%) 4 3
Extensive (30%) 4 3
Pathological characteristics
Heart weight (g) 510 (500–550) 480 (470–550)
Transverse diameter (mm) 124 (123–130) 130 (126–138)
Longitudinal diameter (mm) 110 (101–114) 103 (102–115)
LV free wall thickness (mm) 14 (12–16) 12 (12–14)
Diameter-to-wall thickness ratio 9.1 (7.9–10.8) 9.8 (9.6–11.0)
Biventricular enlargement 2 (20%) 7 (88%)*
uantitative results are expressed as median and interquartile range. *p  0.05 with Fisher exacta
est.
LV  left ventricular; MI  myocardial infarction; PDI  protein disulfide isomerase.nzymatic activity of PDI specifically protects cells from
ndergoing apoptosis in hypoxic conditions.
nfluence of hypoxia on various genes involved in endo-
lasmic reticulum stress response. We used total RNA of
ypoxia-treated HL1 cells to analyze by qRT-PCR the ex-
ression levels of PDI as well as of selected folding catalysts,
ransmembrane kinases, chaperones, and transcription factors
nown to be involved in the unfolded protein response of the
ndoplasmic reticulum (ER) (Fig. 3A). The PDI, Ero1,
RP94, and ATF6-alpha were significantly up-regulated (n
, p  0.05) after exposure to hypoxia. For Ero1 and
TF6-alpha the expression level increased with duration of
ypoxia. The expression level of IRE1-alpha increased
ignificantly (p  0.05) after 48-h exposure to hypoxia but
ot after 24 h. The messenger ribonucleic acid (mRNA)
evel of PERK did not significantly change, whereas the
evel of binding protein (BIP)-mRNA decreased under
nfluence of hypoxia. These results provide independent
onfirmation for the observed up-regulation of PDI during
ypoxia. In addition, the co-upregulation of Ero1 supports
he notion that the enzymatic activity of PDI protects
ardiomyocytes after hypoxic stress. We have also repeated
he qPCR experiments with cells over-expressing PDI.
hese data indicated that over-expression of PDI did not
ignificantly change the expression of the tested genes,
uggesting that the detected effects of PDI over-expression
re direct (data not shown).
uperoxide dismutase-1 is a target of the anti-apoptotic
ction of PDI. To obtain initial insights into protective
echanisms supported by PDI, we investigated whether the
earts
ression of protein disulfide isomerase (PDI) transcript in the ribonucleic acid
a remote from the infarct. The PDI expression in RNA extracted from a nonisch-
istochemical expression of PDI protein in the infarcted area (original magnifica-
rct (original magnification 40). (D) Double staining for PDI protein and terminal
a: only a few cardiomyocytes expressing high levels of PDI were TUNEL positive,
pression and apoptotic rate in the peri-infarct region. (F) Correlation between PDI
sion and biventricular enlargement.ed H
her exp
e are
munoh
e infa
ted are
DI ex
xpresnti-apoptotic effects of PDI were caused by its protective
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ctivity was determined by measuring the release of hydro-
en peroxide (H2O2) generated during the dismutation of 2
uperoxide anions. The HL1 cells over-expressing PDI
howed a significantly higher H2O2 release than HL1 cells
ransfected with the vector alone (Fig. 3B). Therefore, PDI
as able to protect SOD-1 activity, when over-expressed in
L1 cells.
rotective effects of PDI over-expression in the in vivo
cute MI mouse model. The PDI was over-expressed in
n in vivo mouse model of MI by injecting adenoviral
ectors expressing both PDI and GFP (AdPDI/GFP) into
he hearts, before the infarction. As a control, infarcted
earts injected with transgene-null, GFP-expressing adeno-
iral vectors (Adnull/GFP) or hearts from sham-operated
nimals were used. Thirty-one mice were killed at day 7: 13
n the AdPDI/GFP group, 12 in the AdGFP group, and 6
n the sham-operated group.
Efficiency of the viral infection by GFP expression and
ncreased myocardial PDI expression in AdPDI/GFP-
njected mice were verified by Western blots and immuno-
istochemistry (Figs. 4A and 4B). Interestingly, infarct size
as significantly smaller in AdPDI/GFP-treated mice,
Figure 2 PDI Over-Expression Protects HL1 Cardiomyocytes Fro
(A) Endogenous protein disulfide isomerase (PDI) expression is induced under hyp
tions for 24 h and 48 h. The PDI expression was analyzed by Western blotting. (B
cysteine-to-serine mutations in the N-terminal and/or C-terminal thioredoxin-like do
ual clones were estimated by Western blot analysis. (C) Stable over-expression of
hypoxia-induced apoptosis. The HL1 cells were stable transfected with PDI-wt, PDI
periods in hypoxic conditions. The percentage of apoptotic cells was estimated by
ments. *Significant differential apoptotic rate (Student t test, n  5, p  0.001) i
apoptotic rate (Student t test, n  5, p  0.001) in cells transfected with enzyma
tions at 24 h and 48 h.etermined as reduced circumferential extension (18  1% as. 43  1%, p  0.001) and as transmural extension (30 
% vs. 89  1%, p  0.001) assessed in the mid-ventricular
ection (Figs. 4C and 5A to 5D). The apoptotic rate in the
eri-infarct region was also significantly reduced (1.0 
.1% vs. 3.0  0.1%, p  0.001; p  0.001 vs. sham
perated animals [apoptotic rate 0.01  0.001%]) (Figs.
D, 5E, and 5F).
In vivo assessment of the remodeling pattern with trans-
horacic echocardiography confirmed a more favorable pat-
ern in AdPDI/GFP-treated mice. Compared with sham
perated mice, Adnull/GFP-treated infarcted mice had
ignificantly greater LVEDD (p  0.001) and LVESD
p  0.001). Compared with AdGFP animals, AdPDI/
FP mice had significantly smaller LVEDD (2.50  0.02
m vs. 3.11  0.06 mm, p  0.009), similar to that in
ham-operated animals (2.49  0.01 mm, p  0.95) (Fig.
E). A trend toward lower LVESD values in AdPDI/GFP
ersus Adnull/GFP-treated mice was also found (1.31 
.01 mm vs. 1.54  0.03 mm, p  0.054) (Figs. 4E and
F). Finally, we did not find significant differences in the
eft ventricular fractional shortening between AdPDI/GFP
nd Adnull/GFP-treated mice (data not shown).
These data clearly indicate that PDI is over-expressed
poptosis Under Hypoxic Conditions
onditions in mouse cardiomyocytes. HL1 cells were cultured under hypoxia condi-
matic representation of PDI thioredoxin-like domains. The PDI variants have both
. Over-expression of wild-type PDI (PDI-wt), PDI-N, and PDI-C in HL1 stable individ-
t but not of the N- and C-terminal mutants results in a significant protection from
I-C, or empty vector. Stable individual clones were incubated for the indicated
ytometric analysis. Values represent the mean  SE of 5 independent experi-
oxic and hypoxic cardiomyocytes at 24 h and 48 h. **Significant differential
inactive point mutants compared with the control in normoxic and hypoxic condi-m A
oxic c
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September 11, 2007:1029–37 PDI Over-Expression in Human Infarcted Heartseduces infarct size and adverse remodeling, thus suggesting
hat PDI plays a key role in myocardial response to ischemia
nd in postinfarction cardiac remodeling and dilatation.
iscussion
he molecular mechanisms causing remodeling after MI are
till incompletely understood. As a consequence, most
herapeutic approaches to limit injury after infarct, such as
harmacological manipulation and coronary revasculariza-
ion, are based on the observation of a better clinical
utcome associated with myocardial reperfusion or reduced
ardiac work (1). Complex interactions between pro-
poptotic and pro-survival factors occur in the region
ordering the infarct and remote myocardium for days to
eeks after the ischemic event and the apoptotic rate is
orrelated with worse clinical outcome (12). In the current
tudy, we have identified PDI as a key factor of the survival
athway. The PDI belongs to a family of proteins involved
n the UPR system (13), which is activated by stresses that
nterfere with protein folding in the ER. Failure to elimi-
ate misfolded proteins in the ER leads to cell death via
poptosis, and a variety of human disorders are related to
R stress (14). The role of UPR in ischemic diseases has
een studied to a limited extent in the brain (15), tumor
ells (16), and the ischemic heart, suggesting a contribution
Figure 3 Hypoxia Induces the Endoplasmic Reticulum Stress R
Cardiomyocytes, and Zinc-Superoxide Dismutase-1 Is
(A) Total RNA of hypoxia-treated murine HL1 cells was analyzed by quantitative rev
Grp94, binding protein (BIP), and the transcription factors PERK, IRE1-alpha, and A
exposure to hypoxia. (B) Hydrogen peroxide (H2O2) release was measured in HL1
SD from 3 independent measurements. *Significant differential expression (Studeo counteract/repair ischemic damage (17–19). iOur data suggest a significant protective effect of PDI
n human infarcted hearts mediated by a reduction of
poptotic rate and by prevention of cardiac remodeling.
his association is in agreement with the hypothesis that
lso in humans the ER stress response is activated to
ounteract ischemic heart insults. Therefore, we tested
he protective effects of PDI in in vitro and in vivo
odels of hypoxia and ischemia. The in vitro studies
uggest that the enzymatic redox function of PDI (i.e.,
he catalysis for disulfide bond formation) is responsible
or the observed protective effects. Accordingly, forced
xpression of enzymatically inactive point-mutants PDI
36/40S and PDI C383/S387 had no protective effects
ut rather resulted in an increase of apoptotic rate. These
ata indicate that both thioredoxin-like domains are
ritical for this protective function against hypoxic stress,
hich is in agreement with data obtained with glial cells
20). This model is further supported by the observation
hat Ero1, which re-oxidizes reduced PDI, is also
trongly up-regulated after hypoxia. The induction of
DI and Ero1 is mediated by the transmembrane kinase
re1 that is also up-regulated under these conditions.
ecause several other elements of the UPR, such as
rp94/Hsp90 and the transcription factor ATF6, are
lso up-regulated, we propose that this system plays an
nse Genes in HL1
get of the Anti-Apoptotic Action of PDI
ranscriptase polymerase chain reaction for the expression levels of PDI, Ero1,
lpha. *Significant differential expression (Student t test, n  4, p  0.05) after
y horseradish peroxidase-enhanced chemiluminescence. Given are the mean 
st, n  5, p  0.05). Abbreviations as in Figure 1.espo
a Tar
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PDI Over-Expression in Human Infarcted Hearts September 11, 2007:1029–37Both reduced oxygen supply during coronary occlusion
nd the oxidative stress associated with reperfusion cause
rotein folding problems in the ER, because disulfide
ond formation requires oxygen and can be compromised
y reactive oxygen species. Over-expression of PDI is
xpected to counteract such problems. Indeed, significant
Figure 4 PDI Over-Expression Has a Protective Effect in the In
Adenoviral vectors expressing both PDI and green fluorescent protein (GFP) (AdPDI
BL6 mice. A set of animals were killed 48 h after adenoviral administration to det
left coronary artery ligation 48 h after viral administration. One week after the surg
of PDI-wt in C57/BL6 mice. Mice were killed 48 h after adenoviral injections. Wes
homogenized myocardial tissue. (B) Immunohistochemical analysis of GFP and PD
extension, both in terms of extension and thickness, in AdPDI/GFP-injected hearts
respect to the controls. (E) Echocardiographic analysis of the left ventricular end-d
controls. (F) Echocardiographic analysis of the left ventricular end-systolic diamete
viations as in Figures 1 and 2.
Figure 5 Histopathological Analysis of the Infarcted Mice Hear
(A) Hematoxylin/eosin picture of the infarcted heart injected with AdPDI/GFP: the
nal magnification 10). (B) Hematoxylin/eosin picture of the infarcted heart inject
heavy black line (original magnification 20). (C) Hematoxylin/eosin picture of th
interested by the infarct is indicated by a box (original magnification 10). (D) He
involvement of the wall in terms of thickness is indicated by a bold line (original m
AdPDI/GFP and with Adnull/GFP (original magnification 40). (F) Examples of the
nal magnification 40). Abbreviations as in Figure 1.uperoxide generation occurs in cardiomyocytes both
uring ischemia and during reperfusion (21). Over-
xpression of SOD-1, which efficiently dismutases super-
xide, prevents postischemic injury in the heart, attenu-
ting both apoptosis and the inflammatory response
uring ischemia (22). Interestingly, it has been demon-
Acute MI Mouse Model
or GFP only (Adnull/GFP) were administered into the ventricular wall into C57/
the amount of transgene expression. The remaining animals were subjected to
ocedure, mice were killed for analysis. (A) Adenovirus mediated over-expression
ot analyses of GFP and PDI expression were performed with total lysates of
ssion in the injected hearts (original magnification 20). (C) Analysis of infarct
espect to the controls. (D) Analysis of the apoptotic rate in injected hearts with
c diameter (LVEDD) parameter in AdPDI/GFP-injected hearts with respect to the
SD) parameter in AdPDI/GFP-injected hearts with respect to the controls. Abbre-
f the wall of the left ventricle affected by the infarct is indicated by a box (origi-
h AdPDI/GFP: the involvement of the wall in terms of thickness is indicated by a
cted heart injected with Adnull/GFP: the area of the wall of the left ventricle
ylin/eosin picture of the infarcted heart injected with the vector alone: the
ation 20). (E) Examples of TUNEL staining in the infarcted hearts injected with
staining TUNEL-muscle actin to detect only the apoptotic cardiomyocytes (origi-Vivo
/GFP)
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September 11, 2007:1029–37 PDI Over-Expression in Human Infarcted Heartstrated that PDI is over-expressed in familial amyotro-
hic lateral sclerosis, acting as a survival factor through
hysical interaction with SOD-1 (11). This interaction
revents SOD-1 aggregation and consequently neuronal
egeneration. Our findings of increased SOD activity in
yocardiocytes over-expressing PDI are in line with
hese reports and suggest that over-expression of PDI
ight protect myocardial tissue from apoptosis, mediated
y superoxide, through increased SOD activity.
We analyzed the effects of forced PDI expression in a
ouse model of ischemic heart disease. The PDI over-
xpression was associated with a marked reduction of infarct
ize, with a significant reduction of cardiomyocyte apoptosis
n the peri-infarct region, and prevention of cardiac dilata-
ion, as determined in vivo both by transthoracic echocar-
iography and by pathological analysis of explanted hearts.
nterestingly, we did not find significant differences in the
jection fractional shortening between AdPDI/GFP- versus
dnull/GFP-injected mice. This was probably due to the
hort window of time (1 week) after the infarction. Indeed,
he initial increase of cardiac volumes serves the purpose of
reserving the ejection fraction; only late cardiac dilation
ecomes a mechanism of disease resulting in a reduction of
jection fraction and development of HF (23).
The role of apoptosis in the pathophysiology of HF has
een demonstrated, and the potential for preventing isch-
mic cardiomyopathy and HF by inhibiting apoptosis is
romising. Our results from postmortem human hearts and
n vitro and in vivo models of hypoxia and ischemia point
ut a pivotal role for PDI in the programmed survival
athway that promotes cell survival after infarction leading
o more favorable cardiac remodeling. The resulting work-
ng model for cardiomyocytes close to the ischemic region
roposes that PDI acts both on the hypoxic and oxidative
tresses, by contributing to the correct protein folding in
ooperation with ERO-1 and by modulating the activity of
OD-1. When this molecular mechanism is amplified in
ardiomyocytes by over-expression of PDI, the programmed
urvival pathway is strongly ameliorated, resulting in effec-
ive prevention of adverse cardiac remodeling. Pharmaco-
ogical modulation of this pathway might prove useful for
uture prevention and treatment of HF.
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